NCT05454709View on ClinicalTrials.gov

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 29, 2023

Primary Completion Date

December 29, 2023

Study Completion Date

December 29, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Dasiglucagon

Use of dasiglucagon in the AP system.

DRUG

GlucaGen

Use of GlucaGen in the AP system.

Trial Locations (1)

7609 PP

ZGT hospital, Almelo

Sponsors
All Listed Sponsors
lead

Inreda Diabetic B.V.

INDUSTRY